New York - Scientists have found that a new imaging technology allows them to see the widespread loss of brain synapses in early stages of Alzheimer's disease.
The finding may one day help aid in drug development for the brain disorder characterised by memory loss.
The research, published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, compared the density of synapses, which transmit signals between neighbouring brain cells, in people with early stages of Alzheimer's with those of people who have no evidence of the disease.
As expected, the loss of synapses in those with an early stage of Alzheimer's was particularly high in areas surrounding the hippocampus, an area of the brain crucial to formation of memory, the scientists report.
"However, our new methods enable us to detect widespread synaptic losses throughout the brain," said first author of the paper Adam Mecca, Assistant Professor at Yale University in the US.
"This gives us confidence that we may use these results as a biomarker outcome for therapeutic trials, which could help speed development of new drugs to combat the disease."
To get a clearer picture of the early effects of Alzheimer's, the researchers used positron emission tomography (PET) imaging of a protein found in almost all brain synapses.
Previous imaging technologies had been able to show in broad strokes the loss of brain tissue or reduced brain metabolism in Alzheimer's.
However, the new PET scans showed the distribution of synaptic damage, a more specific disease pathology present at early stages of the disease, the authors said.
"These methods will allow us to examine synaptic loss at still earlier stages of disease -- when people have evidence of Alzheimer's pathogenesis but have not yet manifested symptoms," said senior author of the study Christopher van Dyck, Professor at Yale University. (Agency)
Are you an Ayurveda doctor? Download our App from Google PlayStore now!
Download NirogStreet App for Ayurveda Doctors. Discuss cases with other doctors, share insights and experiences, read research papers and case studies. Get Free Consultation 9625991603 | 9625991607 | 8595299366
Washington, Jan 16 (IANS) Nearly 90,000 people in the US may die from Covid-19 in the next three weeks, according to the latest projections of the Centers for Disease Control ...
Washington, Jan 16 (IANS) The overall global coronavirus caseload has topped 93.7 million, while the deaths have surged to more than 2 million, according to the Johns Hopkins ...
Rome, Jan 16 (IANS) Italy passed a positive milestone, with 1 million doses of Covid-19 vaccine having been administered just 19 days after the country launched its nationwide...
Istanbul, Jan 16 (IANS) Turkish President Recep Tayyip Erdogan said he did not see any side effects of the Covid-19 vaccine that he received the previous day.Speaking to the r...